UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

DNA-Binding Anticancer Drugs: One Target, Two Actions

Molecules (Basel, Switzerland), 2021-01, Vol.26 (3), p.552

2021

Volltextzugriff (PDF)

Adaptive homeostasis and the p53 isoform network

EMBO reports, 2021-12, Vol.22 (12), p.e53085-n/a

2021

Volltextzugriff (PDF)

PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors

Nature communications, 2023-11, Vol.14 (1), p.7291-7291, Article 7291

2023

Volltextzugriff (PDF)

Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity

Nature communications, 2021-09, Vol.12 (1), p.5520-5520, Article 5520

2021

Volltextzugriff (PDF)

Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma

Cancer research (Chicago, Ill.), 2017-11, Vol.77 (22), p.6109-6118

2017

Volltextzugriff (PDF)

Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib

PloS one, 2018-04, Vol.13 (4), p.e0195956-e0195956

2018

Volltextzugriff (PDF)

Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner

Molecular cancer therapeutics, 2013-04, Vol.12 (4), p.352-360

2013

Volltextzugriff (PDF)

A Case of mistaken identity: Rhabdomyosarcoma development from endothelial progenitor cells

Molecular & cellular oncology, 2018-07, Vol.5 (4), p.e1448246-e1448246

2018

Volltextzugriff (PDF)

Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors

Cancer cell, 2018-01, Vol.33 (1), p.108-124.e5

2018

Volltextzugriff (PDF)

The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma

Genes, 2024-07, Vol.15 (7), p.906

2024

Volltextzugriff (PDF)

The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer

Cell death & disease, 2019-08, Vol.10 (9), p.631-17, Article 631

2019

Volltextzugriff (PDF)

An unexpected case of pellagra

Medical journal of Australia, 2014-05, Vol.200 (9), p.546-548

2014

Volltextzugriff (PDF)

Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells

Oncotarget, 2015-06, Vol.6 (18), p.16488-16506

2015

Volltextzugriff (PDF)

TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation

Oncotarget, 2016-07, Vol.7 (29), p.46203-46218

2016

Volltextzugriff (PDF)

MDM2-p53 protein–protein interaction inhibitors: A-ring substituted isoindolinones

Bioorganic & medicinal chemistry letters, 2011-10, Vol.21 (19), p.5916-5919

2011

Volltextzugriff (PDF)

Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide

Investigational new drugs, 2011-10, Vol.29 (5), p.1102-1110

2011

Volltextzugriff (PDF)

Abstract PR01: Developmental reprogramming via Hedgehog pathway activation in nonmyogenic endothelial progenitors drives fusion-negative rhabdomyosarcoma

Cancer research (Chicago, Ill.), 2020-06, Vol.80 (11_Supplement), p.PR01-PR01

2020

Volltextzugriff (PDF)

Abstract 3022: Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma indentity

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.3022-3022

2021

Volltextzugriff (PDF)

Abstract 3014: Location specificity in fusion-negative rhabdomyosarcoma driven by cell of origin

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3014-3014

2018

Volltextzugriff (PDF)

A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

Nature communications, 2018-03, Vol.9 (1), p.1107-14, Article 1107

2018

Volltextzugriff (PDF)

Abstract A31: Biallelic Dicer1 loss in endothelial cells drives angiosarcoma development

Cancer research (Chicago, Ill.), 2018-05, Vol.78 (10_Supplement), p.A31-A31

2018

Volltextzugriff (PDF)

Abstract A16: Fusion-negative rhabdomyosarcoma originating from endothelial progenitors

Clinical cancer research, 2018-01, Vol.24 (2_Supplement), p.A16-A16

2018

Volltextzugriff (PDF)

Abstract PR12: Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from nonmyogenic endothelial progenitors

Cancer research (Chicago, Ill.), 2018-10, Vol.78 (19_Supplement), p.PR12-PR12

2018

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(136)
Buchkapitel
(5)

Sprache

Englisch
(140)

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(70)
Humans
(59)
Female
(29)
Physical Sciences
(29)
Crust
(25)
Earth Sciences
(25)
Earth, Ocean, Space
(25)
Exact Sciences And Technology
(25)
Geochemistry & Geophysics
(24)
Velocity Structure
(24)
Internal Geophysics
(23)
Solid-Earth Geophysics, Tectonophysics, Gravimetry
(23)
Geophysical Methods
(22)
Male
(22)
Seismology
(22)
Reflection Methods
(21)
Solid-Earth Geophysics
(21)
Middle Aged
(20)
Oncology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

DNA-Binding Anticancer Drugs: One Target, Two Actions

Adaptive homeostasis and the p53 isoform network

PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors

Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity

Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma

Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib

Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner

A Case of mistaken identity: Rhabdomyosarcoma development from endothelial progenitor cells

Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors

The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma

The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer

An unexpected case of pellagra

Intronic TP53 Polymorphisms Are Associated with Increased [DELTA]133TP53 Transcript, Immune Infiltration and Cancer Risk

Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells

TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation

Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk

MDM2-p53 protein–protein interaction inhibitors: A-ring substituted isoindolinones

Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide

Abstract PR01: Developmental reprogramming via Hedgehog pathway activation in nonmyogenic endothelial progenitors drives fusion-negative rhabdomyosarcoma

Abstract 3022: Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma indentity

Abstract 3014: Location specificity in fusion-negative rhabdomyosarcoma driven by cell of origin

A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

Abstract A31: Biallelic Dicer1 loss in endothelial cells drives angiosarcoma development

Abstract A16: Fusion-negative rhabdomyosarcoma originating from endothelial progenitors

Abstract PR12: Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from nonmyogenic endothelial progenitors

Suchergebnisse filtern